Ari Aminetzah

Ari Aminetzah

A life science veteran with over 25 years of international experience in the industry. Co-founder Ari is a senior life sciences veteran, with executive business development roles among others at J&J and Crucell, a vaccine company sold to J&J for $2.7B. Ari also serves as advisor to the Ministry of Economic Affairs in the Netherlands, McKinsey & Co and multiple ventures in Europe and the USA.

Blog

4 opportunities for patient-centricity in drug development

Ari Aminetzah
Blog

Strong data for start-up and scale-up biotech investments

Ari Aminetzah
Blog

Benefits of including Phase 0 imaging study in your fundraising pitch

Ari Aminetzah
Blog

How to use in-human data as an investment strategy

Ari Aminetzah